Livia Guadagnoli

Dr. Livia Guadagnoli


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2018 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Closed access
PDF file
TTTiffany Taft
Tiffany Taft
JTJ. R. Triggs
J. R. Triggs
DCDustin A Carlson
Dustin A Carlson
LGLivia Guadagnoli
Livia Guadagnoli
KTK. N. Tomasino
K. N. Tomasino
JPJ. E. Pandolfino
J. E. Pandolfino

1 December 2019 in Journal of Asthma and Allergy
Verified
Journal Article
Open access
PDF file
TTTiffany Taft
Tiffany Taft
LGLivia Guadagnoli
Livia Guadagnoli
EEEmily Edlynn
Emily Edlynn
Eosinophilic esophagitis (EoE) is a rapidly emerging chronic disease with limited treatments. Impacting both children and adults, EoE and its treatments have the potential to significantly reduce psychological functioning, including increasing anxiety and depression. In this paper, we provide a scoping review of the scientific literature on anxiety and depression in both pediatric and adult patients. We aim to document the current state of research, identify knowledge gaps, recognize unique challenges that EoE patients may face as they relate to psychosocial function, and offer suggestions for future research directions. Based on the current review, both adult and pediatric patients with EoE are at risk for anxiety and depression symptoms, both due to the disease process and the prevailing dietary treatments. Significant gaps exist in the current understanding of anxiety and depression in EoE, providing ample opportunity for future studies to address this important issue.

11 January 2021 in Neurogastroenterology & Motility
Verified
Journal Article
Closed access
PDF file
LGLivia Guadagnoli
Livia Guadagnoli
RYRena Yadlapati
Rena Yadlapati
TTTiffany Taft
Tiffany Taft
JPJohn E. Pandolfino
John E. Pandolfino
MTMichael Tye
Michael Tye
LKLaurie Keefer
Laurie Keefer

8 April 2025 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
RYRena Yadlapati
Rena Yadlapati
PWPhilip A. Weissbrod
Philip A. Weissbrod
EWErin Walsh
Erin Walsh
TCThomas L. Carroll
Thomas L. Carroll
WCWalter W. Chan
Walter W. Chan
CGC. Prakash Gyawali
C. Prakash Gyawali
INTRODUCTION: The term laryngopharyngeal reflux (LPR) is frequently applied to aerodigestive symptoms despite lack of objective reflux evidence. The aim of this initiative was to develop a modern care paradigm for LPR supported by otolaryngology and gastroenterology disciplines. METHODS: A 28-member international interdisciplinary working group developed practical statements within the following domains: definition/terminology, initial diagnostic evaluation, reflux monitoring, therapeutic trials, behavioral factors and therapy, and risk stratification. Literature reviews guided statement development and were presented at virtual/in-person meetings. Each statement underwent 2 or more rounds of voting per the RAND Appropriateness Method; statements reaching appropriateness with ≥80% agreement are included as recommendations. RESULTS: The term laryngopharyngeal symptoms (LPS) applies to aerodigestive symptoms with potential to be induced by reflux and include cough, voice change, throat clearing, excess throat phlegm, and throat pain. Laryngopharyngeal reflux disease (LPRD) refers to patients with LPS and objective evidence of reflux. Importantly, the presence of LPS does not equate to LPRD. Laryngoscopy has value in assessing for nonreflux laryngopharyngeal processes, but laryngoscopic findings alone cannot diagnose LPRD. LPS patients should be categorized as with or without concurrent esophageal reflux symptoms. While lifestyle modification and empiric trials of acid suppression ± alginates are appropriate when esophageal reflux symptoms coexist, upper endoscopy and ambulatory reflux monitoring are required for LPRD diagnosis when symptoms persist, when LPS is isolated, or when management needs to be escalated to include invasive antireflux management. The two recommended ambulatory reflux monitoring modalities, 24-hour pH-impedance and 96-hour wireless pH monitoring, are not mutually exclusive with distinct roles for the evaluation of LPS. Laryngeal hyperresponsiveness and hypervigilance commonly contribute to both LPS and LPRD presentations and are responsive to laryngeal recalibration therapy and neuromodulators. DISCUSSION: The San Diego Consensus represents the formal modern-day interdisciplinary care paradigm to evaluate and manage LPS and LPRD.

30 June 2023 in Gastroenterology
Verified
Journal Article
Closed access
LGLivia Guadagnoli
Livia Guadagnoli
AGAnnelies Geeraerts
Annelies Geeraerts
HGHannelore Geysen
Hannelore Geysen
APAns Pauwels
Ans Pauwels
TVTim Vanuytsel
Tim Vanuytsel
LOLukas Van Oudenhove
Lukas Van Oudenhove

12 August 2024 in Neurogastroenterology & Motility
Verified
Journal Article
Closed access
SBSarah Ballou
Sarah Ballou
DVDipesh H. Vasant
Dipesh H. Vasant
LGLivia Guadagnoli
Livia Guadagnoli
BRBonney Reed
Bonney Reed
GCGiuseppe Chiarioni
Giuseppe Chiarioni
SKSarah W. Kinsinger
Sarah W. Kinsinger